A combination comprising a therapeutically-effective substantially non- diuretic-effective amount of the aldosterone receptor antagonist spironolactone and a therapeutically-effective amount of an angiotensin II receptor antagonist selected from compounds of the group consisting of saralasin acetate, בקשה חלוקה מס' 160871 מבקשה זו טרם פורסמה. The application for division No. 160871 from this application has not yet been published.
展开▼
